Wanbury Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Wanbury Limited's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 34% of its market value (net debt). Lower than 95% of Healthcare companies in India.
- Growth Efficiency Ratio: Sales grew 29% in 3 years; of every extra ₹100 of sales, ₹53 became extra profit. Higher than 94% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
₹41Over the last 3 years, every ₹100 of reported profit came with ₹41 of operating cash.
Lower than 84% of Healthcare companies in India.
Self-Funding Ratio
0.5×Over the last 3 years its own operating cash paid for 50% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 82% of Healthcare companies in India.
Cash Locked Ratio
₹11For every ₹100 of sales, ₹11 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ₹22 from others' credit three years earlier.
Less money tied up than 73% of Healthcare companies in India.
Growth quality
Steadiness Ratio
3/3 · 2/3Sales grew in 3 of the last 3 years; profit grew in 2 of 3.
Steadier than 53% of Healthcare companies in India.
Growth Efficiency Ratio
₹53Sales grew 29% in 3 years; of every extra ₹100 of sales, ₹53 became extra profit.
Higher than 94% of Healthcare companies in India.
Asset Productivity Ratio
+29% / +71%In 3 years sales changed by +29% while total assets changed by +71%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.5×Debt due within a year is covered 0.5 times by its yearly operating cash.
Lower than 73% of Healthcare companies in India.
Cash Cushion Ratio
−34%Debt, after subtracting cash, equals 34% of its market value (net debt).
Lower than 95% of Healthcare companies in India.
Tangible Assets Ratio
99%Of every ₹100 the company owns, ₹99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 68% of Healthcare companies in India.
Tangible Net Worth Ratio
98%Of every ₹100 of net worth, ₹98 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 58% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Wanbury Limited owes ₹0.72 for every ₹1 it owns. Net profit rose 117% in the year to Mar 2026.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
11.4Investors pay ₹11.4 for every ₹1 of Wanbury Limited's yearly profit, lower than 94% of Healthcare companies in India.
P/B ratio
4.50The share price is 4.50 times Wanbury Limited's book value per share, lower than 53% of Healthcare companies in India.
Market cap
₹650 CrThe total market value of all of Wanbury Limited's shares at today's price (share price × number of shares), smaller than 85% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹144 CrWhat Wanbury Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹41.31Net worth divided by the number of shares. The share price of ₹185.77 is 4.5 times this, which is the P/B above.
Return on equity (ROE)
33.7%Wanbury Limited earned 33.7% on its shareholders' money over the last year, higher than 93% of Healthcare companies in India.
Owes vs Owns
0.72×Wanbury Limited owes ₹0.72 for every ₹1 it owns (moderate), higher than 97% of Healthcare companies in India.
Dividend yield
NoneWanbury Limited does not currently pay a dividend.
Revenue growth
+8%Revenue rose 8% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Profit growth
+117%Net profit rose 117% in the year to Mar 2026.
Profit margin
10.3%Wanbury Limited keeps ₹10 of every ₹100 of revenue as net profit.
Cash quality
0.5×Cash from Wanbury Limited's business was 0.5× its reported profit in the year to Mar 2026 — less cash came in than the profit reported.
Interest cover
9.0×Wanbury Limited's operating profit covered its interest costs 9.0 times in the year to Mar 2026.
Cash vs debt
Net debtWanbury Limited had ₹223 Cr more debt than cash (net debt) at Mar 2026.
Questions
What is Wanbury Limited's P/E ratio?
Investors pay ₹11.4 for every ₹1 of Wanbury Limited's yearly profit, lower than 94% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Wanbury Limited: ₹650 Cr ÷ ₹144 Cr (31 Mar 2026) = 4.5.
What is Wanbury Limited's return on equity?
Wanbury Limited earned 33.7% on its shareholders' money over the last year, higher than 93% of Healthcare companies in India.
How much does Wanbury Limited owe compared with what it owns?
Wanbury Limited owes ₹0.72 for every ₹1 it owns (moderate), higher than 97% of Healthcare companies in India.
Does Wanbury Limited pay a dividend?
No. Wanbury Limited does not currently pay a dividend.
Is Wanbury Limited's revenue growing?
Revenue rose 8% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.